Switch strategy with dolutegravir plus lamivudine in routine clinical practice: persistance and efficacy at 48 and 96 weeks - Palmier, E; Mican, R; Montejano, R; Busca, C; de Miguel, R; Cardinanos, J; Serrano, L; Bernardino, J I; Perez-Valero, I; Moreno, V; Valencia, E; Gonzalez-Garcia, J; et al. (Hiv Medicine, 2021)